1. Pfizer is considering the sale or spin-off of its consumer healthcare business, which generated $3.4 billion in revenue in 2016. The brands at stake include Advil and Chapstick. (Reuters)
2. Express Scripts will acquire EviCore Healthcare, a medical benefits management company, for $3.6 billion. The deal is part of its move into patient benefit management. (Modern Healthcare)
3. The Chinese government plans to speed up drug approvals, in part by allowing drugmakers to submit data from clinical trials in other countries rather than conduct separate studies in China. (Bloomberg)
4. Aerie’s experimental glaucoma treatment Rhopressa effectively lowers eye pressure, the FDA said. An FDA advisory committee is expected to vote this week on whether the FDA should approve the drug. (Reuters)
5. A study found that many patients are confused about the difference between medical students, residents, and attending physicians, and that affects how they feel about their care. (Reuters)
